A comparison of serum haptoglobin levels between acute exacerbation and clinical remission in asthma

Clinical and Experimental Allergy

Volumn 26, Issue 10, 1996, Pages 1202-1209

  Koh, Y Y ^a   Kim, Y W ^a   Park, J D ^a   Oh, J W ^a  

^a Seoul National University Children's Hospital   (South Korea)

Author keywords

Acute exacerbation; Airway inflammation; Bronchial asthma; Clinical remission; Haptoglobin

Indexed keywords

ACUTE PHASE PROTEIN; HAPTOGLOBIN;

ARTICLE; ASTHMA; BLOOD LEVEL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD;

ADOLESCENT; ASTHMA; BLOOD CHEMICAL ANALYSIS; CHILD; FEMALE; HAPTOGLOBINS; HUMANS; MALE; REMISSION INDUCTION;

EID: 0029836593     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00509.x     Document Type: Article

References (39)

1. Bowman BH, Barnett DR, Lum JB, Yang F. Haptoglobin. Methods Enzymol 1988; 163:452-74.
2. Shim BS, Jue DM. Simple spectrophotometric determination of haptoglobin-haemoglobin complex in haemolysed samples. Scand J Clin Lab Invest 1986; 46:45-51.
3. Baumann H and Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
4. Owen JA, Smith R, Padanyi R, Martin J. Serum haptoglobin in diseases. Clin Sci 1964; 26:1-6.
5. Shim BS. Increase in serum haptoglobin stimulated by prostaglandin. Nature 1976; 259:326-7.
6. Fröhlander N, Stendahl U. Haptoglobin groups in ovarian carcinoma. Hum Hered 1988; 38:180-2.
7. Betttendorg A, Colonna J, Favre R, et al. Groupes haptoglobine et cancers bronchique primitifs. Rev Fr Mal Respir 1980; 8:27-30.
8. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. 1989; 83:1013-26.
9. O'Byrne PM, Hargreave FE, Kirby JG. Airway inflammation and hyperresponsiveness. 1987; 136:S35-7.
10. Piessons MF, Marien G, Stevens E. Decreased haptoglobin levels in respiratory allergy. Clin Allergy 1984; 14:287-93.
11. 1, wheezing, bronchial hyperresponsiveness and allergy. Clin Exp Allergy 1991; 21:669-74.
12. Naspitz CK, Ferguson AC, Tinkelman DG. Approaches to the treatment of chronic asthma. In: Tinkelman DG, Naspitz CK, eds. Childhood asthma. Pathophysiology and treatment, 2nd edn. New York: Marcel Dekker, 1993; 329-86.
13. Britton JR, Burney PGJ, Chinn S, Papacosta O, Tattersfield AE. The relation between change in airway reactivity and change in respiratory symptoms and medication in a community study. Am Rev Respir Dis 1988; 138:530-4.
14. Gibson PG, Girgis-Gabardo A, Morris MM et al.. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989; 44:693-9.
15. Djuaknoviç R, Roche WR, Wilson JW et al.. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
16. Fanta CH. Acute asthma. In: Weiss EB, Stein M, eds. Bronchial Asthma. Mechanisms and therapeutics, 3rd edn. Boston: Little, Brown, 1993: 972-84.
17. Sheffer AL. Guidelines for diagnosis and management of asthma. National Institutes of Health, National Asthma Education Program, Bethesda, Maryland, Publication No. 91-3042.
18. Yoon KA, Lim HS, Koh YY, Kim H. Normal predicted values of pulmonary function test in Korean school-aged children. J Korean Pediatr Assoc 1993; 36:25-37.
19. Mancini G, Carbonara AO, Hermans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2:235-54.
20. Ritche RF, Rippey JH. Performance on immunoglobulin G, IgA, and IgM tests in CAP survey specimens. Am J Clin Pathol 1982; 78(Suppl.):644-50.
21. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77:1627-52.
22. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 77:1349-54.
23. Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989; 142:808-12.
24. Boe A, Canosi U, Donini S et al. Determination of haptoglobin expression in IL-6 treated HepG2 cells by ELISA and by RNA hybridization - evaluation of a quantitative method to measure IL-6. J Immunol Methods 1994; 171:157-67.
25. Barnes PJ. Pathophysiology of allergic inflammation. In: Middleton E, Reed CE, Adkinson Jr F, Yunginger JW, Busse WW, eds. Allergy. Principles and Practice, 4th edn. St Louis: Mosby, 1994; 243-66.
26. Gosset P, Tsicopoulos A, Wallaert B et al. Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am Rev Respir Dis 1992; 146:768-74.
27. Mivhel FB, Godard P, Bousquet J. Usefulness of bronchoalveolar lavage in asthmatics. The right clinical practice. Int Arch Allergy Appl Immunol 1989; 88:101-7.
28. Gosset P, Tsicopoulos A, Wallaert B, et al. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991; 88:561-71.
29. Gosset P, Malaquin F, Delneste Y et al. Interleukin-6 and interleukin-1α production is associated with antigen-induced late nasal response. J Allergy Clin Immunol 1993; 92:878-90.
30. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991; 87:794-802.
31. Broide DH, Lotz M, Cuomo AJ et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89:958-67.
32. Michel O, Ginanni R, Le Bon B et al. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis 1992; 146:352-7.
33. Dahl R. Monitoring bronchial asthma in the blood. Allergy 1993; 48:77-80.
34. Griffin E, Hakansson L, Formgren H et al. Blood eosinophil number and activity in relation to lung function in patients with asthma and eosinophilia. J Allergy Clin Immunol 1991; 87:548-57.
35. 20, and exacerbations. Respir Med 1994; 88:613-21.
36. Reynolds TL, Khan MA, van der Linden S, Cleveland RP. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin. Ann Rheum Dis 1991; 50:154-7.
37. Kimber I, Ward RK, Shepherd CJ et al. Acute-phase proteins and the serologic evaluation of experimental contact sensitivity in the mouse, Int Arch Allergy Appl Immunol 1989; 89:149-55.
38. Venge P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respir Med 1995; 89:1-2.
39. Schmitt M, Niggemann B, Kleinau I et al. Lymphocyte subsets, sIL-2R and sICAM-1 in blood during allergen challenge tests in asthmatic children. Pediatr Allergy Immunol 1993; 4:208-13.